Selbyville, Delaware, April 20, 2022 (GLOBE NEWSWIRE) —

Isothermal Nucleic Acid Amplification Technology (INAAT) market value is expected to reach USD 2.8 billion by 2028, according to a new research report by Global Market Insights Inc. Rising number of pathology laboratories and departments equipped with advanced diagnostic systems will drive the expansion of the industry .

Ongoing technological advancements in the healthcare sector will fuel the market demand. Various manufacturers in this market are developing in-house capabilities to develop high quality test kits with fast turnaround times to meet a variety of research needs. Also, the increased demand for advanced amplification, extraction, and sample preparation methods will drive the development of the market. The demand for these test kits for RNA and DNA identification is also likely to increase. Additionally, major manufacturers are partnering with several research institutes to co-develop new test kits and support molecular biology research. Many new companies are expected to enter this market to create new cost-effective diagnostic products and meet the growing medical needs of consumers around the world.

Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/5251

The Nucleic Acid Sequence Based Amplification (NASBA) segment INAAT market exceeded USD 151.7 million in 2021. This is attributed to its increased use in retroviral and microbial detection. Also, the NASBA system is based in part on RNA transcription for amplification, multiple copies of RNA are transcribed in each (theoretical) cycle. As a result, the increased kinetics of the NASBA process is inherently more efficient than PCR amplification.

Key highlights of the Isothermal Nucleic Acid Amplification Technology Market report include:

• The growing prevalence of chronic and infectious diseases around the world will propel the business landscape.
• The growing demand for cost-effective and rapid testing is proving beneficial to the INAAT industry.
• The growing popularity of point-of-care testing will accelerate the progress of the market.
• Government funding and increased R&D activities to develop fully automated diagnostic instruments will drive the market share.

Browse key industry information spread over 160 pages with 235 market data tables and 14 report figures and graphs, “Isothermal Nucleic Acid Amplification Technology (INAAT) Market Forecast by Technology (Loop-Mediated Isothermal Amplification [LAMP]Helicase-dependent amplification [HDA]Amplification based on nucleic acid sequence [NASBA]Strand displacement amplification [SDA]), by product (instruments, reagents), application, (infectious diseases {HIV, influenza, malaria, tuberculosis}, oncology, blood screening), end use (hospitals, diagnostic laboratories), industry analysis report, Regional Outlook, Growth Potential, Competitive Market Share and Forecast, 2022-2028in detail with the table of contents:

https://www.gminsights.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-market

The market for isothermal nucleic acid amplification technology from the instrumentation segment accounted for around 28% of revenue share in 2021. This is due to the increase in diagnostic tests for various infections and chronic diseases. Additionally, the growing number of licensed diagnostic laboratories and increasing elderly population globally will propel the segment’s revenue. Additionally, developments and innovation in various test kits and growing demand for user-friendly diagnostic tests will increase the size of the industry.

The oncology segment held more than 5% revenue share in 2021. This is attributed to the increase in cancer cases globally. For example, according to the National Cancer Institute, in 2020, approximately 1.8 million new cancer cases in the United States were screened by the organization. Thus, to avoid such scenarios, screening and diagnosis of the disease plays a crucial role. For example, the LAMP test from INAAT technology is widely used in the detection of cancer. Such scenarios will boost the expansion of the market.

The hospital segment of the isothermal nucleic acid amplification technology market is expected to grow at a CAGR of 11.4% during the forecasted period. This is due to the high demand for INAAT kits and instruments in the hospital setting. In addition, in hospitals, the risks of preanalytical sampling error, transport of inappropriate samples can be avoided. Such positive scenarios will boost the business outlook. Moreover, the hospitals are well equipped with state-of-the-art equipment as well as the presence of qualified medical professionals. As a result, patients prefer hospitals for any type of diagnosis for better care, thus promoting the overall progress of the market.

Isothermal Nucleic Acid Amplification Technology Market in Asia-Pacific held around 19% business share in 2021. Several countries in Asia-Pacific such as Japan, India, and China are witnessing growing demand diagnostic tests due to the increase in the geriatric population and the increasing prevalence of infectious diseases such as tuberculosis in the region. The growth of the market is also supported by the presence of chains of independent diagnostic centers, hospitals and academic institutes. Additionally, growing demand for cost-effective diagnostics coupled with less stringent regulatory scenarios will increase the regional market prospects.

Request to customize this research report @ https://www.gminsights.com/roc/5251

Some of the major market leaders operating in the isothermal nucleic acid amplification technology industry include BD, Abbott (Alere), BioMerieux SA, Eiken Chemical Co. Ltd, Hologic Inc. (Gen-Probe), Lucigen, Meridian Bioscience, Inc., OptiGene Limited, Qiagen NV, Quidel Corporation, Tecan Genomics Inc., Grifols, SA, Thermo Fisher Scientific Inc. and Ustar Biotechnologies Ltd.

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, USA, is a global provider of market research and advisory services, offering syndicated and custom research reports as well as consulting services. growth. Our business intelligence and industry research reports provide clients with in-depth insights and actionable market data specially designed and presented to aid in strategic decision-making. These comprehensive reports are designed through proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.